Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Structure (London, England : 1993)|June 8, 2017
Crystal Structure of the Cul2-Rbx1-EloBC-VHL Ubiquitin Ligase ComplexTeresa A F Cardote, Morgan S Gadd, Alessio Ciulli
Expert Opinion on Therapeutic Patents|January 21, 2025
A patent review of von Hippel-Lindau (VHL)-recruiting chemical matter: E3 ligase ligands for PROTACs and targeted protein degradation (2019-present)Aina Urbina, Alex J Hallatt, Jack Robertson, et al.
Frontiers in Immunology|December 16, 2024
Unravelling the druggability and immunological roles of the SOCS-family proteinsDylan M Lynch, Beth Forrester, Thomas Webb, et al.
Drug Discovery Today|January 24, 2017
Assessing molecular scaffolds for CNS drug discoveryJoan Mayol-Llinàs, Adam Nelson, William Farnaby, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 25, 2021
MST and TRIC Technology to Reliably Study PROTAC Binary and Ternary Binding in Drug DevelopmentTanja Bartoschik, Andreas Zoephel, Klaus Rumpel, et al.
Nature Reviews. Cancer|April 25, 2025
Targeted protein degradation for cancer therapyMatthias Hinterndorfer, Valentina A Spiteri, Alessio Ciulli, et al.
ACS Chemical Biology|March 14, 2018
Targeting Ligandable Pockets on Plant Homeodomain (PHD) Zinc Finger Domains by a Fragment-Based ApproachAnastasia Amato, Xavier Lucas, Alessio Bortoluzzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2013
Integrated biophysical approach to fragment screening and validation for fragment-based lead discoveryHernani Leonardo Silvestre, Thomas L Blundell, Chris Abell, et al.
Pageof 16